Successful Treatment of Severe Hepatorenal Syndrome with Living Donor Liver Transplantation

被引:3
作者
Demirbas, Baha Tolga [1 ]
Piskin, Turgut [3 ]
Dayangac, Murat
Yaprak, Onur
Oklu, Levent [2 ]
Yuzer, Yildiray
Tokat, Yaman
机构
[1] Sisli Florence Nightingale Hosp, Organ Transplantat Unit, Dept Organ Transplantat, TR-34381 Istanbul, Turkey
[2] Sisli Florence Nightingale Hosp, Dept Anesthesiol, TR-34381 Istanbul, Turkey
[3] Univ Inonu, Dept Gen Surg, Malatya, Turkey
关键词
Hepatorenal syndrome; Liver transplantation; CIRRHOSIS; ASCITES; TYPE-1;
D O I
10.5754/hge10791
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Hepatorenal syndrome is defined as renal failure caused by acute or chronic liver failure without any laboratory or histological reasons. The exact etiology of this syndrome is unknown. However, vasodilatation in the splanchnic area as a result of cirrhosis and portal hypertension, reflex systemic and splanchnic vasoconstriction are the basic pathophysiological reasons of this syndrome. The decrease of renal perfusion, decrease in glomerular filtration rate, sodium retention and deterioration of excretion of free water are the major renal problems and these remain progressive according to the stage of liver disease. The treatment of this syndrome is correction of the underlying problem. Here, we report a patient who was having hemodialysis, due to renal failure as a consequence of liver cirrhosis for three months and returned back to his normal life without a need for dialysis after liver transplantation.
引用
收藏
页码:2305 / 2306
页数:2
相关论文
共 9 条
[1]   Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis [J].
Arroyo, V ;
Gines, P ;
Gerbes, AL ;
Dudley, FJ ;
Gentilini, P ;
Laffi, G ;
Reynolds, TB ;
RingLarsen, H ;
Scholmerich, J .
HEPATOLOGY, 1996, 23 (01) :164-176
[2]   Hepatorenal syndrome in cirrhosis:: Pathogenesis and treatment [J].
Arroyo, V ;
Guevara, M ;
Ginès, P .
GASTROENTEROLOGY, 2002, 122 (06) :1658-1676
[3]  
Bataller R, 1998, KIDNEY INT, V53, pS47
[4]   INCIDENCE, PREDICTIVE FACTORS, AND PROGNOSIS OF THE HEPATORENAL-SYNDROME IN CIRRHOSIS WITH ASCITES [J].
GINES, A ;
ESCORSELL, A ;
GINES, P ;
SALO, J ;
JIMENEZ, W ;
INGLADA, L ;
NAVASA, M ;
CLARIA, J ;
RIMOLA, A ;
ARROYO, V ;
RODES, J .
GASTROENTEROLOGY, 1993, 105 (01) :229-236
[5]   ELECTROLYTE AND CIRCULATORY CHANGES IN TERMINAL LIVER FAILURE [J].
HECKER, R ;
SHERLOCK, S .
LANCET, 1956, 271 (DEC1) :1121-1125
[6]  
Helwig FC, 1932, SURG GYNECOL OBSTET, V55, P570
[7]   Ascites and spontaneous bacterial peritonitis: An Asian perspective [J].
Lee, Jung Min ;
Han, Kwang-Hyub ;
Ahn, Sang Hoon .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 (09) :1494-1503
[8]   Terlipressin therapy for reversal of type 1 hepatorenal syndrome: A meta-analysis of randomized controlled trials [J].
Sagi, Sashidhar V. ;
Mittal, Sahil ;
Kasturi, Krishna S. ;
Sood, Gagan K. .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 (05) :880-885
[9]   RETRACTED: Outcome of Patients With Hepatorenal Syndrome Type 1 After Liver Transplantation: Hangzhou Experience (Retracted article. See vol. 103, pg. 1736, 2019) [J].
Xu, Xiao ;
Ling, Qi ;
Zhang, Min ;
Gao, Feng ;
He, Zenglei ;
You, Jingya ;
Zheng, Shusen .
TRANSPLANTATION, 2009, 87 (10) :1514-1519